Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    September 2016
  1. BHIDE SA, Thway K, Lee J, Wong K, et al
    Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma.
    Br J Cancer. 2016 Sep 1. doi: 10.1038/bjc.2016.
    PubMed     Text format     Abstract available


    July 2016
  2. SRIDHARAN V, Margalit DN, Lynch SA, Severgnini M, et al
    Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.
    Br J Cancer. 2016;115.
    PubMed     Text format     Abstract available


    March 2016
  3. ZEVALLOS JP, Mazul AL, Rodriguez N, Weissler MC, et al
    Previous tonsillectomy modifies odds of tonsil and base of tongue cancer.
    Br J Cancer. 2016;114:832-8.
    PubMed     Text format     Abstract available


  4. TEBBUTT NC, Price TJ, Ferraro DA, Wong N, et al
    Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.
    Br J Cancer. 2016;114:505-9.
    PubMed     Text format     Abstract available


    February 2016
  5. WERNER TA, Tamkan-Olcek Y, Dizdar L, Riemer JC, et al
    Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma.
    Br J Cancer. 2016;114:427-34.
    PubMed     Text format     Abstract available


  6. JANOWITZ T, Thuss-Patience P, Marshall A, Kang JH, et al
    Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data.
    Br J Cancer. 2016;114:381-7.
    PubMed     Text format     Abstract available


  7. WANG C, Guan S, Liu F, Chen X, et al
    Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
    Br J Cancer. 2016;114:290-7.
    PubMed     Text format     Abstract available


    December 2015
  8. BOGDANOVA TI, Zurnadzhy LY, Nikiforov YE, Leeman-Neill RJ, et al
    Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort.
    Br J Cancer. 2015;113:1556-64.
    PubMed     Text format     Abstract available


  9. BOSSI P, Orlandi E, Licitra L
    Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'.
    Br J Cancer. 2015;113:1638-9.
    PubMed     Text format    


    November 2015
  10. LAGARDE SM, Phillips AW, Navidi M, Disep B, et al
    The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence.
    Br J Cancer. 2015;113:1427-33.
    PubMed     Text format     Abstract available


  11. FETONI AR, Paciello F, Mezzogori D, Rolesi R, et al
    Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling.
    Br J Cancer. 2015;113:1434-44.
    PubMed     Text format     Abstract available


  12. DE SILVA N, Schulz L, Paterson A, Qain W, et al
    Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma.
    Br J Cancer. 2015;113:1305-12.
    PubMed     Text format     Abstract available


  13. BYRNE AM, Bekiaris S, Duggan G, Prichard D, et al
    Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion.
    Br J Cancer. 2015;113:1332-42.
    PubMed     Text format     Abstract available


    September 2015
  14. PIRO G, Giacopuzzi S, Bencivenga M, Carbone C, et al
    TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
    Br J Cancer. 2015;113:878-85.
    PubMed     Text format     Abstract available


  15. LIU JY, Li F, Wang LP, Chen XF, et al
    CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.
    Br J Cancer. 2015;113:747-55.
    PubMed     Text format     Abstract available


  16. CAO W, Peters JH, Nieman D, Sharma M, et al
    Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro.
    Br J Cancer. 2015;113:738-46.
    PubMed     Text format     Abstract available


    August 2015
  17. SEN A, Tsilidis KK, Allen NE, Rinaldi S, et al
    Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study.
    Br J Cancer. 2015 Aug 27. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  18. OGUEJIOFOR K, Hall J, Slater C, Betts G, et al
    Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.
    Br J Cancer. 2015 Aug 27. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  19. FEILCHENFELDT J, Varga Z, Siano M, Grabsch HI, et al
    Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).
    Br J Cancer. 2015 Aug 27. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  20. REES J, Hurt CN, Gollins S, Mukherjee S, et al
    Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer.
    Br J Cancer. 2015;113:603-10.
    PubMed     Text format     Abstract available


    July 2015
  21. BHAT GA, Shah IA, Rafiq R, Nabi S, et al
    Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a case-control study in Kashmir, India.
    Br J Cancer. 2015;113:524-32.
    PubMed     Text format     Abstract available


  22. WEBER M, Moebius P, Buttner-Herold M, Amann K, et al
    Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas--an immunohistochemical study.
    Br J Cancer. 2015;113:510-9.
    PubMed     Text format     Abstract available


  23. BARUAH P, Lee M, Wilson PO, Odutoye T, et al
    Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers.
    Br J Cancer. 2015 Jul 14. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  24. WU C, Mikhail S, Wei L, Timmers C, et al
    A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers.
    Br J Cancer. 2015;113:220-5.
    PubMed     Text format     Abstract available


    June 2015
  25. MCCORMICK MATTHEWS LH, Noble F, Tod J, Jaynes E, et al
    Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma.
    Br J Cancer. 2015;113:107-18.
    PubMed     Text format     Abstract available


  26. SUMMERER I, Unger K, Braselmann H, Schuettrumpf L, et al
    Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
    Br J Cancer. 2015 Jun 9. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  27. SGARAMELLA N, Coates PJ, Strindlund K, Loljung L, et al
    Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1.
    Br J Cancer. 2015 Jun 9. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  28. GARNAES E, Kiss K, Andersen L, Therkildsen MH, et al
    Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients.
    Br J Cancer. 2015 Jun 4. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


    May 2015
  29. BOLDRUP L, Coates PJ, Laurell G, Wilms T, et al
    Downregulation of miRNA-424: a sign of field cancerisation in clinically normal tongue adjacent to squamous cell carcinoma.
    Br J Cancer. 2015;112:1760-5.
    PubMed     Text format     Abstract available


  30. RIETBERGEN MM, Witte BI, Velazquez ER, Snijders PJ, et al
    Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe.
    Br J Cancer. 2015;112:1733-6.
    PubMed     Text format     Abstract available


  31. EDEFONTI V, Hashibe M, Parpinel M, Ferraroni M, et al
    Vitamin E intake from natural sources and head and neck cancer risk: a pooled analysis in the International Head and Neck Cancer Epidemiology consortium.
    Br J Cancer. 2015 May 19. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  32. BEG S, Siraj AK, Jehan Z, Prabakaran S, et al
    PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma.
    Br J Cancer. 2015 May 19. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  33. CHANDRANI P, Kulkarni V, Iyer P, Upadhyay P, et al
    NGS-based approach to determine the presence of HPV and their sites of integration in human cancer genome.
    Br J Cancer. 2015 May 14. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


  34. TARABICHI M, Saiselet M, Tresallet C, Hoang C, et al
    Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer.
    Br J Cancer. 2015;112:1665-74.
    PubMed     Text format     Abstract available


    April 2015
  35. MELCHERS LJ, Mastik MF, Samaniego Cameron B, van Dijk BA, et al
    Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.
    Br J Cancer. 2015;112:1349-57.
    PubMed     Text format     Abstract available


  36. FISHER OM, Levert-Mignon AJ, Lord SJ, Lee-Ng KK, et al
    MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.
    Br J Cancer. 2015;112:1384-91.
    PubMed     Text format     Abstract available


    March 2015
  37. BELOUECHE-BABARI M, Box C, Arunan V, Parkes HG, et al
    Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours.
    Br J Cancer. 2015;112:1206-14.
    PubMed     Text format     Abstract available


  38. YOUNG RJ, Urban D, Angel C, Corry J, et al
    Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Br J Cancer. 2015;112:1098-104.
    PubMed     Text format     Abstract available


    February 2015
  39. PETRICK JL, Steck SE, Bradshaw PT, Trivers KF, et al
    Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA).
    Br J Cancer. 2015 Feb 10. doi: 10.1038/bjc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: